共 167 条
[1]
Jochems D(2018)Increased reduction in exsanguination rates leaves brain injury as the only major cause of death in blunt trauma Injury 49 1661-1667
[2]
Leenen LPH(2008)Progression of traumatic intracerebral hemorrhage: a prospective observational study J Neurotrauma 25 629-639
[3]
Hietbrink F(2017)Tranexamic acid update in trauma Crit Care Clin 33 85-99
[4]
Houwert RM(2010)Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 376 23-32
[5]
van Wessem KJP(2011)Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study) BMJ 343 3795-23
[6]
Narayan RK(2019)Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial Lancet 394 1713-27
[7]
Maas AI(2020)Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial Crit Care 24 560-974
[8]
Servadei F(2013)Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial BMC Emerg Med 13 20-2684
[9]
Skolnick BE(2021)Efficacy and safety of tranexamic acid in acute traumatic brain injury: a systematic review and meta-analysis of randomized-controlled trials Intensive Care Med 47 14-45
[10]
Tillinger MN(2020)Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury JAMA 324 961-2533